King Street Closes on Construction Loan for 75 Jackson Rd. in Devens, MA

King Street Properties (“King Street”) announced today the closing of a construction loan for 75 Jackson Road, part of King Street’s 45-acre, 700,000 square-foot Pathway Devens campus, the premier location for advanced manufacturing in the country. Once completed, 75 Jackson Road will add 210,000 square feet of advanced manufacturing space to the growing campus which currently includes tenants Electric Hydrogen, Azzur Group, and Ascend Elements.

Site prep work is nearing completion and King Street will now commence construction on the 75 Jackson Rd. building with a completion date of Q3 2025. This will be the fourth advanced manufacturing building at Pathway Devens.

“We’re excited to deliver our fourth building at Pathway Devens, working with an incredible team of partners and lenders,” says Tyson Reynoso, King Street Managing Director & Partner. “Devens has become a destination for the true drivers of the economy here in Massachusetts.  The confidence in this market, the growth of the advanced manufacturing sector and the demand for GMP space are all reasons we are able to secure a loan for this project.”

Consistent with the rest of the Pathway Devens campus, 75 Jackson is a purpose-built, state of the art facility designed for biomanufacturing and advanced manufacturing. The building features a 12,000-amp power service with redundant feeds as well as an interior clear height of 38 feet.

The lenders for the project are First Citizens Bank and Berkshire Bank, and the project team includes BW Kennedy, Vivo Architecture, and Highpoint Engineering.

About King Street Properties

King Street is a private real estate investment management firm focused on servicing the complex needs of science-based companies and institutions. Headquartered in Boston, King Street’s assets are located in core research hubs including Greater Boston, New York, the Research Triangle in North Carolina, San Diego, and the San Francisco Bay Area.  With 3.5 million square feet of stabilized assets under ownership and management and 4 million square feet in development, King Street is highly experienced in the development and operation of best-in-class life science research and development space and biomanufacturing & pharmaceutical buildings, serving as a trusted partner for companies that develop lifesaving drugs and therapies, medical devices, and companies harnessing renewable materials.